Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus MEDLINE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study.

Title: Results from a prospective longitudinal survey of employment and work outcomes in newly diagnosed cancer patients during and after curative-intent chemotherapy: A Wisconsin Oncology Network study.
Authors: Tevaarwerk AJ; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Division of Hematology/Oncology & Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Kwekkeboom K; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; School of Nursing, University of Wisconsin, Madison, Wisconsin.; Buhr KA; Division of Hematology/Oncology & Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Dennee A; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Conkright W; Fox Valley Hematology/Oncology, Appleton, Wisconsin.; Onitilo AA; Marshfield Clinic, Weston, Wisconsin.; Robinson E; Mercy Health System, Janesville, Wisconsin.; Ahuja H; Aspirus Reg Cancer Center, Wausau, Wisconsin.; Kwong RW; Gundersen Lutheran Med Center, La Crosse, Wisconsin.; Nanad R; Columbia St. Mary's, Milwaukee, Wisconsin.; Wiegmann DA; Division of Hematology/Oncology & Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Chen K; Department of Industrial and Systems Engineering, North Carolina State University, Raleigh, North Carolina.; LoConte NK; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Division of Hematology/Oncology & Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Wisinski KB; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Division of Hematology/Oncology & Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin.; Sesto ME; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin.; Division of Hematology/Oncology & Palliative Care, Department of Medicine, University of Wisconsin, Madison, Wisconsin.
Source: Cancer [Cancer] 2021 Mar 01; Vol. 127 (5), pp. 801-808. Date of Electronic Publication: 2020 Nov 24.
Publication Type: Journal Article; Research Support, N.I.H., Extramural
Language: English
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Imprint Name(s): Publication: : Hoboken, NJ : Wiley; Original Publication: New York [etc.] Published for the American Cancer Society by J. Wiley [etc.]
MeSH Terms: Employment*; Neoplasms/*drug therapy; Adult ; Female ; Humans ; Longitudinal Studies ; Male ; Middle Aged ; Prospective Studies ; Surveys and Questionnaires ; Work Capacity Evaluation
Abstract: Background: Postcancer work limitations may affect a substantial proportion of patients and contribute to the "financial toxicity" of cancer treatment. The degree and nature of work limitations and employment outcomes are poorly understood for cancer patients, particularly in the immediate period of transition after active treatment. We prospectively examined employment, work ability, and work limitations during and after treatment.; Methods: A total of 120 patients receiving curative therapy who were employed prior to their cancer diagnosis and who intended to work during or after end of treatment (EOT) completed surveys at baseline (pretreatment), EOT, and 3, 6, and 12 months after EOT. Surveys included measures of employment, work ability, and work limitations. Descriptive statistics (frequencies, percentages, means with standard deviations) were calculated.; Results: A total of 111 participants completed the baseline survey. On average, participants were 48 years of age and were mostly white (95%) and female (82%) with a diagnosis of breast cancer (69%). Full-time employment decreased during therapy (from 88% to 50%) and returned to near prediagnosis levels by 12-month follow-up (78%). Work-related productivity loss due to health was high during treatment.; Conclusions: This study is the first to report the effects of curative intent cancer therapy on employment, work ability, and work limitations both during and after treatment. Perceived work ability was generally high overall 12 months after EOT, although a minority reported persistent difficulty. A prospective analysis of factors (eg, job type, education, symptoms) most associated with work limitations is underway to assist in identifying at-risk patients.; (© 2020 American Cancer Society.)
Comments: Comment in: Cancer. 2021 Aug 15;127(16):3033-3034. doi: 10.1002/cncr.33566.. (PMID: 34143434); Comment in: Cancer. 2021 Aug 15;127(16):3031-3032. doi: 10.1002/cncr.33569.. (PMID: 34143435)
References: J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686); J Occup Health Psychol. 1998 Oct;3(4):322-55. (PMID: 9805280); Cancer. 2004 Oct 15;101(8):1703-11. (PMID: 15386303); Cancer. 2013 Jun 1;119 Suppl 11:2151-9. (PMID: 23695927); Cancer. 2016 Feb 1;122(3):438-46. (PMID: 26687819); Am J Manag Care. 2009 Nov;15(11):801-6. (PMID: 19895184); Oncology (Williston Park). 2013 Apr;27(4):253-4, 256. (PMID: 23781687); J Clin Oncol. 2018 Jun 10;36(17):1695-1701. (PMID: 29668368); Work. 2016;55(4):783-795. (PMID: 28059814); J Occup Environ Med. 2008 Jul;50(7):777-84. (PMID: 18617833); J Natl Cancer Inst. 2020 Jun 1;112(6):647-650. (PMID: 31599949); MMWR Morb Mortal Wkly Rep. 2014 Jun 13;63(23):505-10. (PMID: 24918485); Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11:S337-49. (PMID: 22588755); Health Aff (Millwood). 2017 Feb 1;36(2):274-281. (PMID: 28167716); Work. 2013;46(4):445-53. (PMID: 24004736); J Cancer Surviv. 2007 Sep;1(3):185-92. (PMID: 18648969); Oncology (Williston Park). 2013 Feb;27(2):80-1, 149. (PMID: 23530397); Cancer Epidemiol Biomarkers Prev. 2020 Mar;29(3):616-624. (PMID: 32132129); Cancer. 2014 Jun 15;120(12):1854-62. (PMID: 24777606); Scand J Work Environ Health. 2010 Sep;36(5):404-12. (PMID: 20372766); Eur J Public Health. 2016 Apr;26(2):301-5. (PMID: 26498956); Oncologist. 2013;18(4):381-90. (PMID: 23442307); J Clin Oncol. 2016 Jan 20;34(3):259-67. (PMID: 26644532); J Cancer Surviv. 2013 Jun;7(2):191-202. (PMID: 23378060); J Clin Oncol. 2013 Oct 20;31(30):3749-57. (PMID: 24043731); J Clin Oncol. 2006 Jan 20;24(3):345-53. (PMID: 16421415); J Health Econ. 2011 May;30(3):505-14. (PMID: 21429606); J Clin Oncol. 2014 Apr 20;32(12):1269-76. (PMID: 24663041); Int J Environ Res Public Health. 2020 Apr 16;17(8):. (PMID: 32316224); CA Cancer J Clin. 2018 Mar;68(2):153-165. (PMID: 29338071); J Clin Oncol. 2020 Mar 1;38(7):734-743. (PMID: 31834818); J Oncol Pract. 2019 Apr;15(4):e300-e307. (PMID: 30844331)
Grant Information: KL2 TR000428 United States TR NCATS NIH HHS; P30 CA014520 United States CA NCI NIH HHS; UL1 TR000427 United States TR NCATS NIH HHS
Contributed Indexing: Keywords: cancer survivorship; cancer work limitations; return to work; working during cancer treatment
Entry Date(s): Date Created: 20201124 Date Completed: 20211015 Latest Revision: 20260512
Update Code: 20260512
PubMed Central ID: PMC7945680
DOI: 10.1002/cncr.33311
PMID: 33231882
Database: MEDLINE

Journal Article; Research Support, N.I.H., Extramural